Eriksson, Linnea <br/><br/>
Glucagon-Like Peptide-1 Receptor Activation Does not Affect Re-Endothelialization but Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Nondiabetic Model of Arterial Injury.  [electronic resource] 

 -  Journal of vascular research  2015 
 - 41-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0135 
<br/><br/><label>Standard No.: </label>10.1159/000381097  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Glucose--analysis<br/>Carotid Artery Injuries--drug therapy<br/>Carotid Artery, Common--drug effects<br/>Cell Division--drug effects<br/>Cells, Cultured<br/>Cyclic AMP--physiology<br/>Disease Models, Animal<br/>Endothelium, Vascular--drug effects<br/>Exenatide<br/>Fatty Acids, Nonesterified--blood<br/>Glucagon-Like Peptide-1 Receptor<br/>Hyperplasia<br/>Insulin--blood<br/>Male<br/>Myocytes, Smooth Muscle--drug effects<br/>Nitric Oxide Synthase Type III--metabolism<br/>Peptides--pharmacology<br/>Random Allocation<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Glucagon--agonists<br/>Regeneration--drug effects<br/>Tunica Intima--drug effects<br/>Vascular Stiffness--drug effects<br/>Venoms--pharmacology